Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
May 8, 2025
BioUtah president and CEO, Kelvyn Cullmore, recently penned an op-ed published in the Deseret News on the need to fix the Inflation Reduction Act’s (IRA) “pill penalty.” The pill penalty refers to a provision in the IRA that allows Medicare to impose government drug negotiations for small-molecule drugs (like pills and tablets) years sooner than for large-molecule drugs (biologics). Cullilmore notes that there are times when government interventions create unanticipated negative consequences. Such is the case with this IRA policy.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
